Albany Medical College

Albany Medical College, a private medical school and academic medical center in Albany, New York, receives federal funding as a grant recipient (91% of awards) and subrecipient for biomedical research, medical education tuition support, and clinical healthcare services. The institution operates as a tax-exempt educational entity, competing in full-and-open federal funding without set-aside designations.

Albany Medical College's federal footprint centers on research and education across neuroscience, infectious disease, cardiovascular biology, and immunology. Representative prime grant work includes a $1.95 million National Institute of Neurological Disorders and Stroke (NINDS) project grant (CFDA 93.853) investigating tumor biomechanics and monoclonal antibody therapeutic efficacy in HER2-positive breast cancer, a $2.46 million Defense Health Agency project grant for dendritic cell targeting to prevent chronic hepatitis B disease, and a $1.63 million National Heart, Lung, and Blood Institute (NHLBI) project grant (CFDA 93.837) on inflammation-resolution mechanisms in endothelial cells and atherosclerosis. Clinical service contracts focus on military medical education and training: the Department of the Navy Bureau of Medicine and Surgery placed multiple delivery orders ranging from $28.8 thousand to $119.9 thousand for tuition and fees supporting Navy medical personnel, alongside a larger $1.61 million Veterans Integrated Service Network 2 definite fixed-price contract for intensive care unit physician services through June 2028.

Customer concentration sits with federal health agencies and the Veterans Affairs system. The top five funding sources—Veterans Affairs (including Veterans Integrated Service Network 2), the National Institutes of Health, the Navy Bureau of Medicine and Surgery, and NIAID—account for 54% of awards by count. By dollars, Veterans Integrated Service Network 2 leads at $25.5 million combined potential value across 51 awards, followed by Navy Bureau of Medicine and Surgery at $5 million across 48 awards. The source shows 542 total awards with $41.1 million in combined potential value, though obligated dollars ($394.2 million) exceed potential value, reflecting prior-year carryover and the institution's long history in federal research funding. Recent activity grew from 13 awards in 2022 to 27 in both 2024 and 2025, with 32 awards (combined potential value $1.7 million) reaching completion within the next twenty-four months.

Subrecipient work positions Albany Medical College across research consortia: the institution serves as sub-recipient under Thomas Jefferson University on cardiac hypertrophy and heart failure research, under Columbia University on HIV healthcare provider training and clinical care improvements, under the University of Florida on neurodegenerative disease clinical trials, and under University of Massachusetts on intrasurgical tissue engineering for bladder reconstruction. The institution also holds institutional sub-awards with New York State agencies—the Department of Health on WIC program administration, the Department of Motor Vehicles on child passenger safety initiatives, and the Division of Criminal Justice Services on forensic examiner services.

Operationally, Albany Medical College sits on five parent government contracts: Navy Indefinite Delivery Contract N0014098G2415 (56 task orders, $5.2 million), VA Indefinite Delivery Contract V528A8P5340 (10 task orders, $4.4 million), and three additional VA vehicle contracts anchoring clinical and research delivery. Service categories by NAICS reflect the dual mission—Offices of Physicians and Colleges/Universities dominate the award count, with General Medical and Surgical Hospitals third, while PSC codes show tuition and registration fees (education support), orthopedic and cardiothoracic surgery services, and medical/radiology work as primary delivery streams.